Upcoming Infectious Diseases Conferences
Conferences By Continents
USA & Americas
Asia-Pacific & Middle East
Conferences By Subject
Target Audience for Infectious Diseases Conferences
With members from around the world focused on learning about global trends on emerging infectious diseases and its advances in therapeutic and diagnostic market, this is your best opportunity to reach the largest assemblage of participants from the Infectious diseases community. These particular stream conferences conduct presentations, distributes information, conducts meetings with current and potential scientists, make a splash with new drug developments, and receive name recognition at these events. World renowned speakers, the most recent therapeutic and diagnostic techniques, developments, and the Novel technologies and therapeutic measures for infectious diseases prevention and control are hallmarks of these conferences.
Directors, Board Members, Presidents, Vice Presidents, Deans and Head of the Departments
Infectious Diseases Researchers, Scientists, Faculties, Students
Infectious Diseases Associations and Societies
Pharmaceutical Companies and Industries
Medical Devices Manufacturing Companies
Drug Manufacturing Companies and Industries
Laboratory Technicians and Diagnostic Companies
Business Entrepreneurs and Industrialists
Software Developing Companies
Data Management Companies
Benefits of Attending CME Conferences (5 lines)
1. They encourage discussions
Live conferences provide doctors with the opportunity to engage in discussions with presenters about educational material, which can help them understand it better.
2. They provide networking opportunities
Attending a conference gives doctors a chance to meet other women’s health professionals from around the U.S.
3. They introduce new ideas and approaches
Learning from an online program can teach doctors new concepts, but attending a conference in person takes this one step further.
4. They offer practical experience
Taking a continuing medical education course online might involve watching videos that show new procedural methods or other demonstrations.
5. They explain new or modified regulations
Doctors can find these regulations online, but the information presented can be confusing and difficult to fully understand.
Benefits of Attending CPD/CE Conferences (5 lines)
- Allows you to fill gaps in your knowledge and skills to become more productive and efficient.
- Builds confidence and credibility to stand out from the crowd
- Achieves your career goals
- Demonstrates professional status
Market Value of Infectious Diseases
The global market for infectious disease treatments was valued at $90.4 billion in 2009. This market is expected to increase at a compound annual growth rate (CAGR) of 8.8% to reach $148 billion in 2016. The largest market share belongs to antibiotic treatments for bacterial and fungal diseases at 53% of the total infectious disease treatment market. Fungal disease treatments will experience a slightly higher compound annual growth rate (CAGR) of 6.2%, from $4.6 billion in 2009 to $6.2 billion in 2014. Viral disease treatments will have the fastest compound annual growth rate (CAGR) of 12.1%, increasing from nearly $45 billion in 2009 to $79 billion in 2016.
Global IVD infectious disease market is expected to reach 25.9 billion by 2022 according to a new report by Grand View Research Inc. Introduction of technologically advanced diagnostic devices along with associated benefits such as rapid result availability, improved accuracy, ease of usage, and cost-effectiveness is expected to serve this market as high-impact rendering drivers over the forecast period. For instance, Abbott Molecular has introduced a new range of real-time assays for HBV and HCV infections on its m200 platform.
The europe molecular diagnostics market is expected to reach USD4.0 billion by 2024, according to a new report by Grand View Research, Inc. Growing geriatric population and the increasing prevalence of neurological and cardiovascular disorders is expected to drive the growth of molecular diagnostics. Moreover, increasing demand for more efficient healthcare delivery to facilitate early diagnostics is further expected to boost market growth.
In Asia and Middle East
Asia-Pacific is expected to register the highest growth rate during the forecast period, owing to the high prevalence of infectious diseases, and huge investment opportunities due to increase in healthcare expenditure. The growth of the IDD market in Asia-Pacific will revolve around China, India, Australia, and New Zealand. Countries in the Middle East will also show growth.